Quantitative, comprehensive multi-pathway signaling analysis using an optimized phosphopeptide enrichment method combined with an internal standard triggered targeted MS assay

Significance of the Topic

Accurate measurement of protein phosphorylation across multiple signaling pathways is essential for understanding cellular regulation in health and disease. Dynamic changes in phosphorylation govern cell growth, metabolism and apoptosis. However, low enrichment specificity and limited sensitivity of traditional phosphoproteomic methods constrain comprehensive pathway analysis.

Study Objectives and Overview

This study presents an integrated workflow combining an optimized sequential metal oxide affinity chromatography (SMOAC) enrichment protocol with a heavy-labeled phosphopeptide standard panel and an internal standard-triggered targeted mass spectrometry assay (SureQuant). The primary goals were to:

• Develop a multipathway assay covering 146 phosphopeptides from 89 signaling proteins.
• Maximize enrichment yield and specificity using TiO2 and Fe-NTA sequential capture.
• Implement an internal standard–triggered MS approach to improve quantitative accuracy and reproducibility.

Methodology and Used Instrumentation

The workflow comprised:

• Cell culture and stimulation of HeLa and A549 cells with EGF or IGF-1 after serum starvation.
• In-solution digestion spiked with 146 AQUA heavy-labeled phosphopeptide standards.
• Sequential enrichment: Hi-Select TiO2 followed by Hi-Select Fe-NTA phosphopeptide kits (SMOAC).
• Offline C18 cleanup and peptide quantitation.
• LC-MS analysis using Dionex nanoLC or EASY-nLC 1200 systems coupled to Orbitrap Exploris 480, Q Exactive HF, and Orbitrap Eclipse mass spectrometers.
• Targeted acquisition via the SureQuant method: real-time detection of heavy internal standards triggers high-sensitivity MS2 of endogenous targets.

Results and Discussion

The optimized SMOAC method significantly increased the number of identified phosphopeptides. Using SureQuant, over 80% of the 146 targets were robustly quantified. PRM analysis demonstrated improved signal-to-noise and sensitivity on the Orbitrap Exploris 480. Differential phosphorylation profiles were observed between HeLa and A549 cells following stimulation, indicating pathway-specific regulation. Reproducibility across replicates and laboratories was high when applying the DIA workflow benchmarked with the heavy standard.

Benefits and Practical Application

This integrated approach delivers:

• Enhanced specificity and yield of multipathway phosphopeptide enrichment.
• Accurate, multiplexed quantitation with minimal missing data.
• Reproducible measurement across different instrument platforms and labs.
• Capability to monitor dynamic phosphorylation changes in signaling networks for research and QA/QC in drug discovery.

Future Trends and Opportunities

Emerging mass spectrometry technologies, such as higher-throughput orbitrap platforms and advanced acquisition algorithms, will further improve multiplexed phosphoproteomics. Integration with data-independent acquisition (DIA) and machine-learning–driven data analysis promises deeper coverage and automated interpretation of complex phosphorylation signatures. Expansion of the heavy standard library to additional post-translational modifications will broaden systems-level functional insights.

Conclusion

The combination of SMOAC enrichment, a comprehensive heavy-labeled phosphopeptide standard, and SureQuant targeted MS establishes a robust, sensitive and reproducible workflow for quantitative multi-pathway signaling analysis. This strategy supports in-depth studies of phosphorylation dynamics and aids biomarker discovery and drug development.

References

1. Logue JS, Morrison DK. Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev. 2012 Apr 1;26(7):641-50.